COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
24 09 2021
Historique:
received: 13 07 2021
revised: 10 08 2021
accepted: 11 08 2021
pubmed: 2 9 2021
medline: 24 9 2021
entrez: 1 9 2021
Statut: ppublish

Résumé

To describe COVID-19 vaccine distribution operations in United States Federal Bureau of Prisons (BOP) institutions and offices from December 16, 2020-April 14, 2021, report vaccination coverage among staff and incarcerated people, and identify factors associated with vaccination acceptance among incarcerated people. The BOP COVID-19 vaccination plan and implementation timeline are described. Descriptive statistics and vaccination coverage were calculated for the BOP incarcerated population using data from the BOP electronic medical record. Coverage among staff was calculated using data from the Centers for Disease Control and Prevention Vaccination Administration Management System. Vaccination coverage in the BOP versus the overall United States adult population was compared by state/territory. Univariate and multivariable logistic regression models were developed to identify demographic, health-related, and institution-level factors associated with vaccination acceptance among incarcerated people, using hierarchical linear modeling to account for institution-level clustering. By April 14, 2021, BOP had offered COVID-19 vaccination to 37,870 (100%) staff and 88,173/126,413 (69.8%) incarcerated people, with acceptance rates of 50.2% and 64.2%, respectively. At the time of analysis, vaccination coverage in BOP was comparable to coverage in the overall adult population in the states and territories where BOP institutions and offices are located. Among incarcerated people, factors associated with lower vaccination acceptance included younger age, female sex, non-Hispanic Black and Asian race/ethnicity, and having few underlying medical conditions; factors associated with higher acceptance included having a prior SARS-CoV-2 infection, being born outside the United States, and being assigned to a Federal Detention Center. Early COVID-19 vaccination efforts in BOP have achieved levels of coverage similar to the general population. To build on this initial success, BOP can consider strategies including re-offering vaccination to people who initially refused and tailoring communication strategies to groups with lower acceptance rates.

Identifiants

pubmed: 34465473
pii: S0264-410X(21)01078-1
doi: 10.1016/j.vaccine.2021.08.045
pmc: PMC8363472
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5883-5890

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1139-1143
pubmed: 32817597
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222
pubmed: 33571174
J Natl Med Assoc. 2021 Feb;113(1):6-7
pubmed: 33583497
JAMA. 2020 Dec 29;:
pubmed: 33372943
Am J Public Health. 2021 Jun;111(6):1164-1167
pubmed: 33856883
Harm Reduct J. 2019 Jul 5;16(1):42
pubmed: 31277665
Am J Prev Med. 2021 Jul;61(1):120-123
pubmed: 33781619
J Health Care Poor Underserved. 2018;29(4):1544-1557
pubmed: 30449762
N Engl J Med. 2021 Jul 22;385(4):374-376
pubmed: 33979505
MMWR Morb Mortal Wkly Rep. 2021 Apr 02;70(13):473-477
pubmed: 33793457

Auteurs

Liesl M Hagan (LM)

Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, 1600 Clifton Road NE, Atlanta, GA 30333, United States; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States. Electronic address: vqf8@cdc.gov.

Charles Dusseau (C)

Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: cdusseau@bop.gov.

Michael Crockett (M)

Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mcrockett@bop.gov.

Tami Rodriguez (T)

Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: t1rodriguez@bop.gov.

Michael J Long (MJ)

Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mzlong@bop.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH